Skip to content
ClearheadLab
Explore

A calm evidence note

Ginkgo vs Bacopa for Memory: Which Herbal Nootropic Has Better Evidence?

Large ginkgo trials found no dementia-prevention benefit. Bacopa studies give mixed results on recall in healthy adults.

Written with care by Nadia BrooksUpdated
On this page

Our nootropic ranking

Five branded stacks, graded on trials

Ranked on whether the finished product — not just an ingredient in it — was ever put in a published trial, and how the actives are dosed against the studied range.

Compare nootropic stacks

Not an ad · none of the five is an affiliate partner, no row links to a seller, and nothing in that ranking is ordered by money.

Ginkgo biloba and Bacopa monnieri are the two herbal memory supplements most likely to share a shelf — and the two most likely to be sold with the same vague "sharper, clearer mind" promise. But that shared marketing hides a real difference in the evidence, and that difference is the whole point of this comparison. Ginkgo has one of the largest human evidence bases of any herbal nootropic — and for healthy memory it is mostly disappointing and unreliable. Bacopa has a smaller stack of trials — but they are more consistently positive for a narrow slice of memory, even if the effect is modest and slow. The honest one-line verdict: for a healthy adult hoping to remember more, Bacopa has the better (if modest) evidence, and Ginkgo is well-tolerated but not a dependable memory booster. This article walks through how the two compare on evidence quality, what each actually does, the practical differences, and who (if anyone) should pick which.

These are supplements, not drugs. Neither Ginkgo nor Bacopa is approved to treat, prevent, or cure brain fog, memory loss, dementia, or any condition, and nothing here is medical advice. If your memory or focus problems are new, worsening, or interfering with daily life, the first move is to rule in a real, treatable cause — sleep debt, thyroid or iron issues, B12 deficiency, depression, medication side effects — which we cover in our guide to causes of brain fog. A herbal capsule is the wrong first response to something genuinely wrong, no matter which herb it is.

What the studies can tell us

There are larger studies on ginkgo and dementia prevention than on bacopa and everyday memory. Those are different outcomes. Comparing the studies can show what each supplement has been tested for, but cannot establish which works better.

Ginkgo vs Bacopa, side by side

DimensionGinkgo biloba (EGb 761)Bacopa monnieri (bacosides)
Size of evidence baseVery large — one of the most-studied herbal nootropicsSmall and few trials, mostly older RCTs
Consistency / qualityLow certainty (Cochrane)Mixed results across extracts and cognitive tests
Healthy-adult memoryNo reliable benefitSome positive recall tests, with a newer null trial
Preventing declineNo benefit — large prevention trials (GEM) negativeNot really studied for prevention
Speed of onsetWeeks to months — but mostly failed regardlessSlow: ~12 weeks of daily dosing
Main safety cautionBleeding / platelet risk — caution with blood thinners, surgeryMostly GI upset — taken with food
Honest verdictWell tolerated, but not a reliable memory boosterBetter (if modest) evidence for healthy-adult memory
Older bacopa trials reported some recall benefits. A more recent 12-week trial found no cognitive benefit.

Ginkgo: heavily studied, mostly unreliable for healthy memory

Ginkgo biloba (the leaf extract, standardized in trials to the EGb 761 flavonoid-and-terpene profile) has an attractive mechanistic story — antioxidant activity and improved cerebral blood flow — and a deep stack of trials to test it. The trouble is what those trials returned. The Cochrane review's verdict of inconsistent, unreliable, low-certainty evidence is a damning conclusion for one of the field's most-researched compounds1. The prevention story is even clearer: large, well-conducted trials designed to test whether ginkgo could keep healthy or at-risk older adults from declining — most famously the GEM (Ginkgo Evaluation of Memory) study — did not find that ginkgo prevented dementia or slowed decline. The single most aspirational use, taking it now to protect your memory later, has the clearest negative answer.

The one place a faint signal survives is symptomatic dementia: a meta-analysis of EGb 761 in patients who already have dementia reported a modest cognitive and functional benefit at higher doses, under medical care2. But that is a clinical population managed by clinicians — not a healthy adult chasing better recall — and the overall Cochrane verdict of inconsistent, unreliable evidence still frames how much weight even that can carry1. The full evidence picture is in our Ginkgo biloba for memory review.

Bacopa: mixed results on recall

A small randomized trial in healthy adults reported better retention of new information after 12 weeks of a standardized bacopa extract3. Other older studies found benefits on some memory tests45. A newer 12-week placebo-controlled trial in healthy adults with self-reported memory and attention problems found no cognitive benefit from a different bacopa extract6.

The studies used different extracts and tests, which makes the results hard to compare. The bacopa review explains what the individual studies measured.

The honest verdict

Bacopa edges it on evidence — Ginkgo is well tolerated but unreliable

  • Some older bacopa trials reported better recall, but a newer placebo-controlled trial found no cognitive benefit.
  • Ginkgo has the bigger evidence base but the Cochrane review rates it inconsistent and unreliable, and prevention trials (GEM) were negative.
  • Bacopa is slow — about 12 weeks of daily dosing — and its certainty is still graded low to very low; set modest expectations.
  • Safety differs: Ginkgo carries a real bleeding-interaction caution (blood thinners, surgery); Bacopa most commonly causes GI upset.
  • Whichever you consider, rule in the real cause of your fog first — a leaf extract is the wrong first move for something genuinely wrong.
What the studies found for recall, prevention, and safety.

The practical differences: speed, target, and tolerability

Beyond evidence quality, the two behave differently in ways that matter for a buyer. Speed: neither is a same-day pill, but Bacopa is emphatically slow — the trials that worked dosed it daily for roughly 12 weeks3, so a one-week trial proves nothing. Ginkgo's trials also ran for weeks to months, but since they mostly failed in healthy people, its "onset" is somewhat academic. Target: Bacopa's cleanest effect is delayed recall and retention4; Ginkgo has no dependable healthy-adult target at all. Tolerability: both are generally well tolerated, but their caution flags differ — Ginkgo's stands out for bleeding risk (it can affect platelet function, so it warrants real caution with blood thinners, bleeding disorders, and before surgery), while Bacopa's most common issue is gastrointestinal (nausea, cramping), which is why it is taken with food. Anyone pregnant or breastfeeding, or on other medications, should talk to a clinician before starting either.

So which should you pick?

For a healthy adult hoping to improve memory, neither supplement has a dependable benefit. Ginkgo did not prevent dementia in large trials, and the findings on bacopa and recall are mixed. Ginkgo can interact with blood thinners, so discuss it with a clinician if you take them or have surgery coming up.

The bottom line

The strongest answer is about ginkgo and dementia prevention: large trials did not find a benefit. Some older bacopa trials reported better recall, but a newer placebo-controlled trial found no cognitive benefit after 12 weeks36. There is no reliable evidence from these studies that one supplement improves everyday memory more than the other.

A few gentle questions

Ginkgo vs Bacopa — which is better for memory?

There is no reliable answer for healthy adults. Some older bacopa trials reported better recall, but a newer 12-week trial found no cognitive benefit. Ginkgo has not shown dependable benefits for healthy-adult memory or dementia prevention.

Does Ginkgo have more research than Bacopa?

Yes. Ginkgo has been studied in large dementia-prevention trials and did not reduce dementia incidence. Bacopa trials are smaller and have found mixed results on memory and attention.

How long do Ginkgo and Bacopa take to work?

Neither is a same-day pill. Bacopa is emphatically slow — the trials that found a memory benefit dosed it daily for roughly 12 weeks, so a one-week trial proves nothing. Ginkgo's trials also ran for weeks to months, but since they mostly failed to show benefit in healthy people, its onset is somewhat academic. If you take either for a few days and feel nothing, that's exactly what the chronic-dosing trials would predict.

Are there safety differences between Ginkgo and Bacopa?

Both are generally well tolerated, but their caution flags differ. Ginkgo's most notable risk is bleeding: it can affect platelet function, so be cautious if you take blood thinners (warfarin, aspirin, clopidogrel, DOACs), have a bleeding disorder, or are heading into surgery. Bacopa's most common issue is gastrointestinal — nausea or cramping — which is why it's taken with food. Anyone pregnant or breastfeeding, or taking other medications, should talk to a clinician before starting either.

Where this comes from

  1. Wieland LS, Ludeman E, et al. (2026). Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews. https://pubmed.ncbi.nlm.nih.gov/41641880/
  2. Feng JX, Zheng MQ, et al. (2025). Ginkgo biloba extract EGb 761 in patients with dementia. Frontiers in Neurology. https://pubmed.ncbi.nlm.nih.gov/41908799/
  3. Stough C, Lloyd J, Clarke J, et al. (2001). The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects.. Psychopharmacology (Berl). https://pubmed.ncbi.nlm.nih.gov/11498727/
  4. Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, et al. (2014). Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/24252493/
  5. Brimson JM, Brimson S, Prasanth MI, et al. (2021). The effectiveness of Bacopa monnieri (Linn.) Wettst. as a nootropic, neuroprotective, or antidepressant supplement: analysis of the available clinical data.. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/33436817/
  6. Lopresti AL, et al. (2025). The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Drug Investigation. https://pubmed.ncbi.nlm.nih.gov/41091332/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.